Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Climacteric. 2020 Nov 11;24(3):214–228. doi: 10.1080/13697137.2020.1834529

Table 1.

Overview of Epidemiologic Studies including Midlife Latinas

Study Country Purpose Study Years Baseline Age (Years) N Latina % Sex Hormones VMS Health Behaviors Cardio-metabolic Factors Psychological Factors and QOL
Hilo Women’s Health Study Hawaii, USA To assess general health, menopause status, and health-related complaints among adult women in Hilo, Hawaii. 2004–2005 40–60 994 0.9 N/A Yes Diet/Nutrition; Physical activity; Smoking; Alcohol BMI; Blood pressure; Hypertension; Diabetes; Cholesterol N/A
San Francisco Midlife Women’s Health Study (SFMWHS) San Francisco, CA, USA To describe changes in the biopsychosocial health of midlife women through the menopausal transition. 1996–2001 40–48 347 27.4 Urine: FSH Yes Sleep quality BMI Social support; Stress; Discrimination
Seattle Midlife Women’s Health Study (SMWHS) Seattle, WA, USA To describe the menopause transition in terms of personal and social factors, hormone changes, stress, health behaviors, and symptoms in midlife women. 1990–2013 35–55 508 1.2 Urine: FSH, estrone, testosterone Yes Diet/Nutrition; Physical activity; Sleep quality; Alcohol BMI; Hypertension; Diabetes; Anxiety; Depression; Stress
Study of Women’s Health Across the Nation Ann Arbor, MI; Boston, MA; Chicago, IL; Alameda and Contra Costa County, CA; Los Angeles, CA; Jersey City, NJ; and Pittsburgh, PA, USA To examine the physical, biological, psychological and social changes of midlife women during the menopause transition. 1996-Current 42–52 3302 8.7 Serum: FSH, estradiol, testosterone, SHBG Yes Diet/Nutrition; Physical activity; Smoking; Sleep quality; Alcohol; Illicit Drugs BMI; Blood pressure; Hypertension; Diabetes; Lipids; Subclinical vascular measures; CVD Anxiety; Childhood adversity; Depression; Social support; Stress; Discrimination; QOL
The Decision at Menopause Study (DAMES- USA) MA, USA To better understand the various factors that influence therapeutic decisions by middle-aged women related to the burden of menopause symptoms. 2001–2002 45–55 293 1.00 N/A Yes Physical activity; Smoking; Alcohol BMI N/A

Note. FSH = follicle stimulating hormone, N/A = not applicable, QOL = quality of life, SHBG = sex hormone binding globulin, VMS = vasomotor symptoms